Registration is open and the staff of Today’s Medical Developments, Aerospace Manufacturing and Design, Today’s Motor Vehicles, and Today’s Energy Solutions, published by GIE Media Inc., wants IMTS exhibitors and attendees to be a part of the inaugural Miles for Manufacturing 5K event.
Chicago – Make plans to attend the IMTS 2014 Conferences to learn about How to Determine if Laser Hot Wire Cladding is Right for Your Application.
DATE: Thursday, September 11 from 3:15 PM - 4:10 PM ROOM: W-194B
SPEAKER: Paul Denney, Senior Laser Applications Engineer, The Lincoln Electric Company
While there are many welding processes you can utilize for cladding and hardfacing, not all are ideal for the deposition of large amounts of material where minimal heat and dilution are needed. The more common arc processes, such gas tungsten arc welding (GTAW) or gas metal arc welding (GMAW), often require multiple layers to reach the proper chemistry and tend to deposit thicker layers with more heat input. To address these issues of arc processing, laser cladding with powder has been accepted in some applications; however, it has lower deposition rates and high “overspray” (material that does not stick to the clad). A potential process that can address many of these issues is laser hot wire cladding. This process uses a laser as the primary heat source like the powder based cladding processes but augments this heat with resistance heating of the wire using an advanced welding power supply.
This presentation will focus on the advantages of laser hot wire cladding over other welding processes, outline the cost savings potential and explain how to know if it’s the right process for your application.
The educational and informative conferences run Sept. 8-11, 2014 in the West Building, Level 1. To register for this or any session, visit www.imts.com/education/imtsconference.html.
The US Food and Drug Administration (FDA) has given 510(k) clearance to Spectranetics' peripheral atherectomy products, Turbo-Tandem and Turbo Elite, used to treat in-stent restenosis (ISR). Approval is based on data from the 'excImer laser randomised controlled study for treatment of femoropopliteal (arteries above and behind the knee) in-stent restenosis' (EXCITE ISR) clinical trial.
Spectranetics said it received positive statistical result in terms of safety and efficacy during a trial of the products on 250 patients earlier this year.
Genesis Heart Institute principal investigator Eric Dippel said: "With mean lesion length at 20cm, approximately one-third of the patients being re-treated for ISR and also approximately one-third with total occlusions, EXCITE represents a very sick, real-world patient set.
"The highly superior outcomes for both safety and efficacy and the delta in procedural success rates between the two arms of the trial are compelling.
"Given that a significant number of patients today are treated with PTA alone with very poor outcomes, EXCITE demonstrates a proven treatment algorithm that physicians and their patients need."
Initially, 318 patients were planned to be enrolled for randomised prospective EXCITE ISR trial at up to 35 sites.
Spectranetics president and CEO Scott Drake said: "FDA-clearance of our peripheral atherectomy devices to treat ISR is a landmark moment for Spectranetics and patients worldwide.
"We are the only company with indicated devices, our primary competitors are contraindicated; we possess clinical data that will change clinical practice and a scaled commercial team to capitalize on this $750 million market opportunity."
The trial demonstrated superior safety and efficacy of laser atherectomy with adjunctive PTA compared with PTA alone.
It also showed a 94% procedural success rate using laser atherectomy with PTA versus 83% with PTA alone.
The primary efficacy endpoint of the trial is freedom from TLR through six months, while the primary safety endpoint is freedom from major adverse events (MAEs) at 30 days.
New York – Cyborgs are a staple of science fiction – from “Star Wars” to “Star Trek” and “The Terminator.”
But some real-life cyborgs are emerging. And while they aren’t exactly half-human, half-machine, they are using implantable technology in remarkable ways.
Chicago, Illinois – Manufacturers today are more focused than ever on reducing costs and improving efficiency by streamlining their automation processes. Such relevant manufacturing topics and trends will be highlighted during the inaugural Motion, Drive & Automation North America (MDA North America 2014) and Industrial Automation North America (Industrial Automation NA 2014) events co-located with the IMTS Show at McCormick Place in Chicago from Sept. 8-13, 2014. Hannover Fairs USA (HFUSA), the organizer of both business-to-business trade shows, has gathered industry experts to lead its event conference programs, including The MDA Conference and The Global Automation & Manufacturing Summit.
The MDA Conference
On Tuesday, Sept. 9, 2014, Hannover Fairs USA in partnership with GIE Media will host The MDA Conference. During this all-day program, experts will discuss best practices in motion control, power transmission, and fluid power. Topics range from industrial communications, robotic control, guidance and inspection, linear actuators and 3D printing. Speakers from Beckhoff Automation, Festo Corporation and Rollon Corporation will discuss the latest advancements in each of these areas. Program sessions will also highlight practical end-user applications about how to apply cutting-edge technology to increase efficiency and improve safety. To register for the MDA Conference, visit the registration page.
The Global Automation & Manufacturing Summit
On Wednesday, Sept. 10, 2014, Hannover Fairs USA in partnership CFE Media will present The Global Automation & Manufacturing Summit. This full day of cutting-edge content and information will focus on topics ranging from industrial automation, mobility and maintenance practices to information management. Experts from Chicago’s Digital Manufacturing and Design Innovation Institute, McGladrey, Molex and Sur-Seal Corporation will offer valuable manufacturing insights to help attendees implement change, to keep up with industry challenges and to meet their operating goals. To register for the Global Automation & Manufacturing Summit, visit the registration page.
The ISA Training Workshop
During a two-day workshop from Sept. 10 - 11, The ISA Training Workshop will feature educational sessions focused on using the ANSI/ISA-62443 standards to protect and secure an Industrial Control System (IC32). The workshop will also explore the procedural and technical differences between the security for traditional IT environments and those solutions appropriate for SCADA or plant floor environments. The course is required for the ISA99/IEC 62443 Cybersecurity Fundamentals Specialist Certificate Program and offers 1.4 continuing education unit credits. For more information about the ISA Training Workshop, visit the registration page.
About Industrial Automation NA 2014 and MDA North America 2014
Following the trade show’s launch in 2012, Industrial Automation NA is well on its way to becoming North America’s leading trade show for process, factory and building automation. Industrial Automation NA has already distinguished itself as the showplace for the automation industry’s most innovative solutions and technologies. Industrial Automation and Motion, Drive & Automation are two of the foremost trade shows of HANNOVER MESSE, the world’s leading trade fair for industrial technology held in Hannover, Germany. Other Industrial Automation and Motion, Drive & Automation events are held in Brazil, China, India, Italy, and Turkey. For more information, go to the website.
Source: Hannover Fairs USA